Global Respiratory Infections Diagnostics Market (2021-2025) – By Technology, Plex, Location, Product & Region –

DUBLIN – (COMMERCIAL THREAD)–The “Respiratory infection diagnostic markets by technology, plex, location, product and region with impact and Covid-19 forecast / analysis, and 2021-2025 executive guides and consultants” report was added to offer.

COVID-19 has opened up the market for point-of-care respiratory infection testing. Now the competition for market share is starting in earnest. Big new markets are opening up. In health facilities, clinics, doctors’ offices and elsewhere. And let’s not forget the testing market, not only for COVID, but the rest of the 20 respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors attempt to position themselves in new markets that are not yet fully understood.

New technologies are forever changing the diagnosis of respiratory infections. The reduction in the time to obtain results opens up markets several times larger than the current practice based on microbiology. The diagnosis has already moved to the emergency room. He is now moving to the lab in the doctor’s office. Could the house be next?

The multiplex factor is confusing the market while reducing costs and improving care, but important factors are holding back progress. The widespread nature of respiratory infections (young people can catch 8 colds a year) means that the potential size of the market is huge. Respiratory diseases, already the largest category of infectious diseases, could increase. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this detailed report.

Our research makes you the expert in your organization. Make our research team work for you by ordering all or part of this full report. Your credit card order instantly sends the report to your inbox. Check all your licensing options but don’t worry, your order is available as a credit if you want to move on to more information. We have written this report and are ready, by phone or email, to help you use it. As always, support and additional specific data are provided at no additional cost.

Companies mentioned

  • Abacus Diagnostica

  • Abbott Diagnosis

  • Speed ​​up diagnostics

  • Ador Diagnostics

  • Akonni biosystems

  • Alveo Technologies

  • BioCode applied

  • Aus Diagnostics

  • Beckman Coulter Diagnosis

  • Becton, Dickinson and company

  • Binx Health

  • Biocartis

  • bioMérieux Diagnostics

  • Bio-Rad Laboratories, Inc.

  • Bosch Healthcare Solutions GmbH

  • Cepheid (now Danaher)

  • Co-Diagnosis

  • Credo Diagnostics Biomedical

  • Health index

  • Curetis SA / Curetis GmbH

  • Diagénode Diagnostics

  • Diascopic

  • Diasorin SpA

  • Enzo Life Sciences, Inc

  • Eurofins Scientific

  • Fluxergie

  • Lightning Genetics

  • Fusion genomics

  • Genetic signatures

  • GenMark Dx

  • Hibergene diagnosis

  • Hologically

  • Immunexpress

  • Inflammatix

  • Invetech

  • Janssen diagnosis

  • Karius

  • Lexagen

  • LightDeck diagnostics

  • Luminex Corp

  • Lumos diagnostic

  • Mammoth Biosciences

  • Maxim Biomedical

  • Meridian bioscience

  • Mesa Biotech

  • Millipore Sigma

  • Mindray

  • Mobidiag

  • Ecological

  • Nanomix

  • Operon

  • Oxford Nanopore Technologies

  • Panagen

  • Perkin Elmer

  • Primerdesign

  • Prominex

  • Qiagen GmbH

  • Quantumdx

  • Quidel

  • Roche Molecular Diagnostics

  • Saw diagnosis

  • Seegene

  • Siemens Healthineers

  • Sona Nanotech

  • SpeedDx

  • T2 Biosystems

  • Thermo Fisher Scientific Inc.

  • Veramarx

  • Veredus Laboratories

  • Visby Medical

  • XCR diagnostics

Main topics covered:

1 Market guide

2 Market introduction and definition

3 Market overview

4 market trends

4.1 Growth factors

4.1.1 Syndromic multiplexing

4.1.2 TAT

4.1.3 Antimicrobial Resistance Movement

4.1.4 Pandemic mitigation

4.1.5 An aging population at risk

4.2 Factors limiting growth

4.2.1 The cost curve

4.2.2 Regulation and coverage

4.2.3 laissez-faire

4.3 Instrumentation and automation

4.3.1 The retractable multiplexing machine

4.3.2 Bioinformatics Networking and Anonymous Reporting

4.4 Development of diagnostic technology

4.4.1 The key role of result time

4.4.2 Single-cell genomics is a game-changer

4.4.3 Pharmacogenomics confuses diagnosis and treatment

4.4.4 Identification of pathogens – A provisional timetable for the future

5 Diagnosis of respiratory infections Recent developments

6 profiles of key players

7 The Global Respiratory Infections Diagnostics Market

8 Global Respiratory Infections Diagnostics Markets – By Technology

9 Global Respiratory Infections Diagnostics Markets – By Plex

10 Global Respiratory Infections Diagnostics Market – By Location

11 Global Respiratory Infections Diagnostics Market – By Product

12 Appendices

For more information on this report, visit

Source link

About Clara Barnard

Clara Barnard

Check Also

Global DNA & RNA Banking Services (Storage Service, Quality Control Service) Market Trends, Analysis & Forecast Report 2021-2028

DUBLIN, October 07, 2021– (COMMERCIAL THREAD)–The Global DNA & RNA Banking Services Market Size, Share …